FR2860518B1 - Procede pour le diagnostic/pronostic du neuroblastome - Google Patents

Procede pour le diagnostic/pronostic du neuroblastome

Info

Publication number
FR2860518B1
FR2860518B1 FR0311483A FR0311483A FR2860518B1 FR 2860518 B1 FR2860518 B1 FR 2860518B1 FR 0311483 A FR0311483 A FR 0311483A FR 0311483 A FR0311483 A FR 0311483A FR 2860518 B1 FR2860518 B1 FR 2860518B1
Authority
FR
France
Prior art keywords
neuroblastoma
prognosis
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0311483A
Other languages
English (en)
Other versions
FR2860518A1 (fr
Inventor
Alexander Krause
Valerie Combaret
Bruno Lacroix
Alain Puisieux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Centre Leon Berard
Original Assignee
Biomerieux SA
Centre Leon Berard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA, Centre Leon Berard filed Critical Biomerieux SA
Priority to FR0311483A priority Critical patent/FR2860518B1/fr
Priority to US10/572,905 priority patent/US20060263784A1/en
Priority to EP04805718A priority patent/EP1668163A2/fr
Priority to PCT/FR2004/050475 priority patent/WO2005030992A2/fr
Publication of FR2860518A1 publication Critical patent/FR2860518A1/fr
Application granted granted Critical
Publication of FR2860518B1 publication Critical patent/FR2860518B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0311483A 2003-10-01 2003-10-01 Procede pour le diagnostic/pronostic du neuroblastome Expired - Fee Related FR2860518B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0311483A FR2860518B1 (fr) 2003-10-01 2003-10-01 Procede pour le diagnostic/pronostic du neuroblastome
US10/572,905 US20060263784A1 (en) 2003-10-01 2004-10-01 Method for the diagnosis/prognosis of neuroblastoma
EP04805718A EP1668163A2 (fr) 2003-10-01 2004-10-01 Procede pour le diagnostic/pronostic du neuroblastome
PCT/FR2004/050475 WO2005030992A2 (fr) 2003-10-01 2004-10-01 Procede pour le diagnostic/pronostic du neuroblastome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0311483A FR2860518B1 (fr) 2003-10-01 2003-10-01 Procede pour le diagnostic/pronostic du neuroblastome

Publications (2)

Publication Number Publication Date
FR2860518A1 FR2860518A1 (fr) 2005-04-08
FR2860518B1 true FR2860518B1 (fr) 2006-02-17

Family

ID=34307308

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0311483A Expired - Fee Related FR2860518B1 (fr) 2003-10-01 2003-10-01 Procede pour le diagnostic/pronostic du neuroblastome

Country Status (4)

Country Link
US (1) US20060263784A1 (fr)
EP (1) EP1668163A2 (fr)
FR (1) FR2860518B1 (fr)
WO (1) WO2005030992A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1683862B1 (fr) * 2003-09-25 2012-08-01 Chiba-Prefecture Microreseau d'evaluation de pronostic neuroblastome et procede d'evaluation de pronostic de neuroblastome
EP1742060A1 (fr) * 2005-01-24 2007-01-10 DIGILAB BioVisioN GmbH Acides nucléiques et peptides de TIF1-beta pour le diagnostic et le traitement du cancer et des maladies colorectals cancéreuses.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672040A (en) * 1983-05-12 1987-06-09 Advanced Magnetics, Inc. Magnetic particles for use in separations
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4981783A (en) * 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US5750338A (en) * 1986-10-23 1998-05-12 Amoco Corporation Target and background capture methods with amplification for affinity assays
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
CA2020958C (fr) * 1989-07-11 2005-01-11 Daniel L. Kacian Methodes d'amplification de sequences d'acide nucleique
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
DE60239087D1 (de) * 2001-05-30 2011-03-10 Chiba Prefecture Aus einem Neuroblastom isolierte Nukleinsäuren

Also Published As

Publication number Publication date
WO2005030992A3 (fr) 2006-04-06
FR2860518A1 (fr) 2005-04-08
WO2005030992A2 (fr) 2005-04-07
US20060263784A1 (en) 2006-11-23
EP1668163A2 (fr) 2006-06-14

Similar Documents

Publication Publication Date Title
FR2869698B1 (fr) Procede pour le controle et le diagnostic de machines
FR2891379B1 (fr) Procede et systeme de diagnostic des pannes pour aerodynes
DE602004024630D1 (de) Ultraschalldiagnosegerät
IL188165A0 (en) Method for the diagnosis of alzheimer's disease
DE602004028817D1 (de) Schraubverbindung für stahlrohre
FR2881437B1 (fr) Procede pour le diagnostic/pronostic d'un syndrome septique
FR2906287B1 (fr) Installation pour la pratique d'activites aquatiques
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
FR2863275B1 (fr) Procede pour le diagnostic/pronostic du cancer du sein
FR2889403B1 (fr) Procede de fabrication d'un transducteur acoutique
FR2869030B1 (fr) Procede de production d'alpha-alumine particulaire
FR2886946B1 (fr) Procede pour le diagnoctic/pronostic du cancer du sein
FR2886051B1 (fr) Procede de detachement d'un film mince
FR2891380B1 (fr) Procede et systeme de validation des defaillances pour aerodynes
FR2860518B1 (fr) Procede pour le diagnostic/pronostic du neuroblastome
DE602006021093D1 (de) Aufzeichnungsvorrichtung und Steuerverfahren für die Aufzeichnungsvorrichtung
DE602004004839D1 (de) System für den öffentlichen Internetzugang und Gerät zum Anschluss an die Zugangsleitung
FR2877229B1 (fr) Procede de surveillance de soupape d'un doseur d'anesthesique
HK1090392A1 (en) Methods for the diagnosis and prognosis of alzheimers disease
AU2003266302A1 (en) Method for the diagnosis of alzheimer disease
FR2821161B1 (fr) Procede de diagnostic pour reconnaissance de modeles de defaut
DE60311142D1 (de) Verfahren für die magnetische resonanzbildgebung
FR2888843B1 (fr) Procede de preparation d'un diarylanthracene.
DE60307027D1 (de) System für die Mediendetektion
DE60031212D1 (de) Vorrichtung für Ultraschalldiagnose

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20110630